HOOKIPA Pharma
HOOK
HOOK was delisted on the 7th of August, 2025.
0 hedge funds and large institutions have $0 invested in HOOKIPA Pharma in 2025 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 6 closing their positions.
100% less funds holding
Funds holding: 6 → 0 (-6)
100% less capital invested
Capital invested by funds: $824K → $0 (-$824K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 6
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KCM
Knoll Capital Management
Miami,
Florida
|
-$461K |
| 2 |
JC
JBF Capital
Aspen,
Colorado
|
-$321K |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
-$25K |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$16.7K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
-$466 |
HOOK Hedge Fund Activity: Q4 2025 in Review
0 of the 8,286 institutional investors tracked by Wall St. Rank reported a position in HOOKIPA Pharma (HOOK) for Q4 2025, worth a combined $0 — down 100% from $824K a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of HOOK and 0 opened new positions — a net loss of 6 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Knoll Capital Management, exiting entirely with an estimated $461K sold.
- 0 institutional investors held HOOKIPA Pharma (HOOK) as of Q4 2025, down from 6 in Q3 2025.
- Funds reported $0 of HOOKIPA Pharma stock for Q4 2025, down 100% quarter-over-quarter.
- 0 funds opened new HOOKIPA Pharma positions in Q4 2025 and 6 closed out, a net change of -6 holders.
- The largest HOOKIPA Pharma seller in Q4 2025 was Knoll Capital Management, an estimated $461K sold.
Based on aggregated 13F filings for Q4 2025.